# US 2019/0168001 A1 · Neurostimulation and recording of physiological response for the treatment of chronic cardiac dysfunction

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0168001 A1
- Document ID: US20190168001A1
- Status: Published application
- Kind: A1
- Application number: 16/265,765
- Filed: 2019-02-01
- Published: 2019-06-06
- Earliest claimed: 2014-04-25
- Assignees: LivaNova USA, Inc.; East Tennessee State University
- Applicants: Livanova USA, Inc.; East Tennessee State University
- Inventors: Imad Libbus; Badri Amurthur; Bruce H. KenKnight; Jeffrey L. Ardell
- Web page: https://patentgrep.com/patent/US20190168001A1

## CPC

- A61N 1/36139: {with automatic adjustment}
- A61N 1/0551: {Spinal or peripheral nerve electrodes}
- A61N 1/36053: {adapted for vagal stimulation (A61N1/36114 takes precedence)}
- A61N 1/36114: {Cardiac control, e.g. by vagal stimulation (stimulating the heart A61N1/362)}
- A61N 1/36146: {specified by the stimulation parameters}
- A61N 1/36171: {Frequency}
- A61N 1/36157: {Current (A61N1/3616 takes precedence)}
- A61N 1/3627: {for treating a mechanical deficiency of the heart, e.g. congestive heart failure or cardiomyopathy}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)

## Abstract

Systems and methods are provided for delivering neurostimulation therapies to patients for treating chronic heart failure. A neural fulcrum zone is identified and ongoing neurostimulation therapy is delivered within the neural fulcrum zone. The implanted stimulation device includes a physiological sensor for recording the patient's response to the neurostimulation therapy on an ambulatory basis over extended periods of time.

## Claims

### Claim 1

A neurostimulator adapted to deliver a stimulation signal to a patient, said stimulation signal comprising an ON time and an OFF time, the neurostimulator comprising:
a control system comprising a processor configured to:
activate the neurostimulator to deliver the stimulation signal;
during the OFF time of the stimulation signal, acquire a baseline signal comprising a baseline heart rate from a heart rate sensor;
during the ON time of the stimulation signal, acquire a response signal comprising a heart rate response from the heart rate sensor; and
change an intensity of the stimulation signal, based on the baseline signal and the response signal, to cause a transition heart rate response in the patient, the transition heart rate response being between tachycardia and bradycardia and comprising a heart rate change between the baseline heart rate and the heart rate response that is less than a predefined threshold.

### Claim 2 (depends on 1)

The neurostimulator of claim 1, wherein the control system is further configured to periodically record the baseline signals and the response signals for a period of at least one week.

### Claim 3 (depends on 1)

The neurostimulator of claim 1, wherein the control system is further configured to periodically record the baseline signals and the response signals for a period of at least one month.

### Claim 4 (depends on 1)

The neurostimulator of claim 1, wherein the control system is further configured to periodically record the baseline signals and the response signals for a period of at least one year.

### Claim 5 (depends on 1)

The neurostimulator of claim 1, wherein the control system is configured to transmit recorded baseline signals and response signals to an external computing device.

### Claim 6 (depends on 1)

The neurostimulator of claim 1, wherein the stimulation signals are configured to treat a chronic cardiac dysfunction.

### Claim 7 (depends on 1)

The neurostimulator of claim 1, wherein the stimulation signals are vagus nerve stimulation signals.

### Claim 8 (depends on 1)

The neurostimulator of claim 1, wherein the control system is configured to acquire the baseline signal after a delay period following completion of the ON time of the stimulation signal.

### Claim 9 (depends on 1)

The neurostimulator of claim 1, wherein the control system is configured to acquire the response signal after a delay period following initiation of the ON time of the stimulation signal.

### Claim 10 (depends on 1)

The neurostimulator of claim 1, wherein the control system is further configured to calculate a baseline signal average of a plurality of OFF times of the stimulation signal and to calculate a response signal average of a plurality of ON times of the stimulation signal.

### Claim 11

A method of operating a neurostimulator adapted to deliver a stimulation signal to a patient, said stimulation signal comprising an ON time and an OFF time, the method comprising:
activating the neurostimulator to deliver the stimulation signal;
during the OFF time of the stimulation signal, acquiring a baseline signal comprising a baseline heart rate from a heart rate sensor;
during the ON time of the stimulation signal, acquiring a response signal comprising a heart rate response from the heart rate sensor; and
changing an intensity of the stimulation signal, based on the baseline signal and the response signal, to cause a transition heart rate response in the patient, the transition heart rate response between tachycardia and bradycardia and comprising a heart rate change between the baseline heart rate and the heart rate response that is less than a predefined threshold.

### Claim 12 (depends on 11)

The method of claim 11, further comprising periodically recording the baseline signals and the response signals for a period of at least one week.

### Claim 13 (depends on 11)

The method of claim 11, further comprising periodically recording the baseline signals and the response signals for a period of at least one month.

### Claim 14 (depends on 11)

The method of claim 11, further comprising periodically recording the baseline signals and the response signals for a period of at least one year.

### Claim 15 (depends on 11)

The method of claim 11, further comprising transmitting recorded baseline signals and response signals to an external computing device.

### Claim 16 (depends on 11)

The method of claim 11, wherein the stimulation signals are configured to treat a chronic cardiac dysfunction.

### Claim 17 (depends on 11)

The method of claim 11, wherein the stimulation signals are vagus nerve stimulation signals.

### Claim 18 (depends on 11)

The method of claim 11, wherein acquiring the baseline signal comprises acquiring the baseline signal after a delay period following completion of the ON time of the stimulation signal.

### Claim 19 (depends on 11)

The method of claim 11, wherein acquiring the response signal comprises acquiring the response signal after a delay period following initiation of the ON time of the stimulation signal.

### Claim 20 (depends on 11)

The method of claim 11, further comprising:
calculating a baseline signal average of a plurality of OFF times of the stimulation signal; and
calculating a response signal average of a plurality of ON times of the stimulation signal.
